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Abstract
Background: Existing molecular assays for filarial parasite DNA in mosquitoes cannot distinguish between infected
mosquitoes that contain any stage of the parasite and infective mosquitoes that harbor third stage larvae (L3) capable of
establishing new infections in humans. We now report development of a molecular L3-detection assay for Brugia malayi in
vectors based on RT-PCR detection of an L3-activated gene transcript.
Methodology/Principal Findings: Candidate genes identified by bioinformatics analysis of EST datasets across the B. malayi
life cycle were initially screened by PCR using cDNA libraries as templates. Stage-specificity was confirmed using RNA
isolated from infected mosquitoes. Mosquitoes were collected daily for 14 days after feeding on microfilaremic cat blood.
RT-PCR was performed with primer sets that were specific for individual candidate genes. Many promising candidates with
strong expression in the L3 stage were excluded because of low-level transcription in less mature larvae. One transcript
(TC8100, which encodes a particular form of collagen) was only detected in mosquitoes that contained L3 larvae. This assay
detects a single L3 in a pool of 25 mosquitoes.
Conclusions/Significance: This L3-activated gene transcript, combined with a control transcript (tph-1, accession # U80971)
that is constitutively expressed by all vector-stage filarial larvae, can be used to detect filarial infectivity in pools of mosquito
vectors. This general approach (detection of stage-specific gene transcripts from eukaryotic pathogens) may also be useful
for detecting infective stages of other vector-borne parasites.
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Introduction
Lymphatic filariasis (LF) is a disabling tropical disease that is
caused by filarial nematode parasites that are transmitted by
mosquitoes. Brugia malayi and B. timori account for approximately
10% of the global LF burden of 120 million infected individuals
[1]. The Global Programme to Eliminate Lymphatic Filariasis
(GPELF) has the ambitious goal of eliminating this disease by the
year 2020 [2]. The program is largely based on a strategy of mass
drug administration (MDA) of antifilarial medications to endemic
populations with the aim of reducing human infection rates to
levels that cannot sustain transmission by mosquitoes.
Improved tools are needed for monitoring progress in LF
elimination programs. Currently, there are diagnostic assays to
measure antigenemia [3], microfilarial loads, and antifilarial
antibodies in humans [4,5]. PCR detection of filarial DNA in
mosquito vectors, termed molecular xenomonitoring (MX), is an
important tool for indirectly detecting the presence of filarial
infections in the human population [6–12]. MX is highly sensitive
and is less intrusive than human blood collection for monitoring
filarial infections in communities [13,14]. However, positive DNA
detection in vectors does not necessarily indicate that transmission is
ongoing in a community. This is because PCR assays detect any
stage of the parasite present in the vector, not just the infective stage
(L3). Fischer and colleagues have recently shown that filarial DNA
can be detected by PCR in non-vector species for at least two weeks
following the ingestion of infected blood [15]. Thus, while filarial
DNA assays efficiently detect filarial parasites in communities, they
may not accurately reflect transmission of new infections.
A specific molecular test for infective mosquitoes would be a
useful tool for monitoring the success of LF elimination programs.
Although other diagnostic tools are available to measure LF in
communities, ‘‘the ultimate test of interruption of transmission
rests on infectivity rates of the mosquito vectors’’ [16]. Until now,
the only way to measure infectivity in mosquitoes was by the
laborious method of mosquito dissection. Dissection is not
practical for detecting and measuring mosquito infection and
infectivity rates when rates are very low following MDA.
This paper describes a B. malayi mRNA transcript that is first
expressed in mosquitoes by infective larvae (a ‘‘L3-activated
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transcript’’) and the development of a RT-PCR assay based on this
transcript to detect L3 in mosquitoes. Molecular L3 detection can
be used to screen large numbers of mosquitoes. This new tool
holds great promise as a means of monitoring LF elimination
programs and for detecting resurgent transmission of filariasis
following the completion of MDA programs.
Methods
Bioinformatics selection of gene candidates
The B. malayi EST database [17] has been assembled into
clusters of homologous sequences that each represent one gene by
The Institute for Genomic Research (TIGR) [18]. We searched
the B. malayi Gene Index Database (http://compbio.dfci.harvard.
edu/tgi/cgi-bin/tgi/gimain.pl?gudb =b_malayi) for candidate L3-
activated genes that might be useful as targets for an L3-detection
assay in mosquitoes. Target genes were called ‘L3-activated’
because their expression did not have to be limited to the to L3s
for them to be useful for detecting infective mosquitoes. ‘‘L3-
activated’’ genes are first expressed in L3 larvae. Thus, expression
in the L4 through mature adult stages (the mammalian host stages)
would not exclude a gene from being a potential target for
detecting L3 larvae in mosquitoes. Of course, genes that are
expressed in less mature filarial larvae in mosquitoes (e.g., Mf, L1
or L2) would not be useful for this purpose. The primary search
criterion used to select gene candidates from the database was
expression in BmL3 or BmL4 stage cDNA libraries with no
expression in pre-L3 stage libraries. Other gene targets were
included for testing based on previous reports of larval specificity
[19] or on previous bioinformatics analyses of the B. malayi
Expressed Sequence Tag (EST) dataset [20]. Candidate genes
were removed from the list of potential targets in the following
situations: 1) a BlastN search of the dbEST database (http://www.
ncbi.nlm.nih.gov/BLAST/) yielded orthologous genes from other
filarial species that were expressed in mf, L1, or L2 stage parasites;
or 2) when intron-exon boundaries could not be determined. Exon
boundary identification was necessary for primer and probe design
in order to prevent detection of corresponding genomic DNA
(gDNA) sequences.
PCR screening of candidate L3-activated genes using
cDNA libraries
Intron-exon boundaries were identified in the genomic
sequences obtained from the B. malayi Genome Project [21]
(www.tigr.org) using the mRNA-to-genomic DNA alignment
program, SPIDEY (www.ncbi.nlm.nih.gov/spidey). Specific prim-
ers were designed for each candidate gene with the Oligo 5.1
primer design program (National Biosciences, Plymouth, MN).
One primer for each gene was designed to span an exon-exon
boundary to reduce the possibility of amplifying contaminating
genomic DNA in cDNA library preparations. PCR was performed
with phage template (2.5 ml) from the available stage-specific
cDNA libraries: BmMf, BmL2, and BmL3 (available at http://
www.filariasiscenter.org/ which is supported by NIAID contract
RR211-258/6582667) in a 25 ml reaction with PCR buffer
(Applied Biosystems, Inc.), 600 nM dNTPs, 200 nM each forward
and reverse primer, 1.5 mM magnesium chloride, and Taq Gold
enzyme (Applied Biosystems, Foster City, CA). Cycling parameters
were 94uC for 10 min, 55uC for 5 min, followed by 35 cycles of
72uC for 90 sec, 94uC for 45 sec, 55uC for 45 sec, and a 10 min
extension at 72uC. PCR products were detected by agarose gel
electrophoresis. Candidate genes were excluded from further
testing if amplification products were detected in the BmMf or
BmL2 cDNA libraries.
Mosquito feeding on microfilaremic blood
Infected Aedes aegypti (black-eyed Liverpool strain, AeL)
mosquitoes were provided by the Filariasis Research Reagent
Repository Center (FR3) at the University of Georgia (http://
www.filariasiscenter.org/para-center/division.htm). Mosquitoes
had been fed on blood from microfilaremic cats using artificial
feeders with a natural skin membrane. Microfilaria counts in cat
blood ranged from 80 to 150 mf per 20 ml. Blood-fed mosquitoes
were maintained in an insectary at 27uC with 80% humidity.
Mosquitoes were collected each day for 14 days and immediately
preserved in RNAlater (Ambion). This period covered the extrinsic
incubation period for B. malayi in mosquitoes. The FR3 center also
provided uninfected control mosquitoes (either unfed or after
feeding on blood from uninfected cats).
RNA extraction from mosquito pools
RNA was extracted from pools of 5–8 mosquitoes using a
phenol/guanidine thiocyanate extraction procedure. Preliminary
studies showed that this method provided a more consistent and
higher yield and quality of RNA than extractions using column
based methods (data not shown). Mosquitoes were removed from
RNAlater, blotted on a kimwipe to remove excess salt, and
processed in pools in 2 mL round-bottom microcentrifuge tubes.
Not all mosquitoes that fed on the infected blood were expected to
have taken up parasites or to have supported the parasite’s
development Therefore, 2 or 3 mosquitoes that had fed on
infected blood were included in each pool to increase the
probability of having parasites present in each mosquito pool.
Five biological replicates of all time points were tested. TRI
reagent (Ambion, Inc.), a monophasic solution of phenol and
guanidine thiocyanate, and glycogen [50 ug/mL] were added to
each pool of mosquitoes, along with a zinc-plated 4.5-mm steel
ball bearing (BB) (Daisy Outdoor Products, Rogers, AR). The
parafilm sealed tubes were vortexed horizontally on high speed for
30 minutes for tissue disruption. Manufacturer’s instructions were
Author Summary
The Global Programme for the Elimination of Lymphatic
Filariasis (GPELF) was launched in the year 1998 with the
goal of eliminating lymphatic filariasis by 2020. As the
success of mass drug administration (MDA) in the global
program drives the rates of infection in endemic popula-
tions to very low levels, the development of new, highly
sensitive methods are required for monitoring transmis-
sion by screening mosquitoes for the presence of L3
infective larvae. The current method of mosquito dissec-
tion to identify L3 larvae is laborious and insensitive and is
not amenable to screening large numbers of mosquitoes.
Existing molecular assays for the detection of filarial
parasite DNA in mosquitoes are sensitive and can easily
screen large numbers of vectors. However, current PCR-
based methods cannot distinguish between infected
mosquitoes that contain any stage of the parasite and
infective mosquitoes that harbor third stage larvae (L3)
capable of establishing new infections in humans. This
paper reports the first development of a molecular L3-
detection assay for a filarial parasite in mosquitoes based
on RT-PCR detection of an L3-activated gene transcript.
This strategy of detecting stage-specific messenger RNA
from filarial parasites may also prove useful for detecting
infective stages of other vector-borne pathogens.
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followed for TRI-reagent RNA extraction (Ambion, Inc.). This
included the use of 1-bromo-3-chloropropane for the separation of
the homogenate into aqueous and organic phases. To facilitate the
removal of proteoglycan and polysaccharide contaminants, the
RNA was precipitated using isopropanol with the addition of a
high salt solution (0.8 M sodium citrate and 1.2 M NaCl), washed
with 75% ethanol, and resuspended in 1 mM sodium citrate,
pH 6.4 (RNA Storage Solution, Ambion, Inc.). To reduce
genomic DNA contamination, all samples were treated with
‘‘DNA-free’’ (Ambion, Inc.) as per the manufacturer’s instructions.
RNA samples were evaluated using a Nanodrop spectrophotom-
eter (NanoDrop technologies, Wilmington, DE) for quantity and
purity.
Conventional RT-PCR testing of infected mosquitoes
Conventional RT-PCR and multiplex RT-PCR reactions were
performed using the OneStep RT-PCR kit (Qiagen, Inc.) with
buffer containing 2.5 mM magnesium chloride, 0.4 mM dNTPs,
600 nM of the forward and reverse primers, 1 ml enzyme mix and
1 ml RNA template in a 25 ml total volume. The thermal cycling
conditions used were 50uC for 30 min, 95uC for 15 min, and 55uC
for 5 min, followed by 40 cycles of 72uC for 90 sec, 94uC for
45 sec, 55uC for 45 sec, and a 10 min extension step at 72uC.
PCR products were electrophoresed on a 3% agarose gel, detected
by ethidium bromide staining and visualized with ultraviolet light.
The primers used in the multiplex conventional RT-PCR for the
control gene tph-1 amplify a 153 bp fragment from all stages of the
parasite (#1054 59-AAGGACGGCAAGTAGTAAGGA-39 and
#1059 59-AACAGTTCATTTCTTGTAGC-39). The primers for
the L3-activated gene TC8100 amplify a 120 bp fragment (#1213
59-TTTATTCATTAAAAGGCTTAGCATCT-39 and #1207
59-CATTTTGTAATGATATTCATCTCGAA-39).
qRT-PCR testing of mosquito pools
The Taqman OneStep RT-PCR kit (Applied Biosystems, Inc.,
Foster City, CA) was used according to manufacturer’s instructions
except the total reaction volume was 25 ml instead of 50 ml. The
Primer Express v2.0 program (Applied Biosystems, Inc.) was used to
design primer/probe sets for real time qRT-PCR. A 6-Fam labeled
minor groove binding (MGB) probe was used for detection of the L3-
activated gene products while a Taqman probe (Applied Biosystems,
Inc.) was used for detection of the control gene products (tph-1). Both
probes were designed to span an exon-exon boundary in order to
prevent detection of any amplification resulting from residual
genomic DNA contamination in the purified RNA. The primer
sequences used for amplification of Bm-TC8100 were #1442 Bm-
TC8100.F 59-CCTGGTTTAAGCGGACAGGA-39, and #1443
Bm-TC8100.R 59-GCTGGCATGTTACCTGGAAGA-39. The
MGB probe sequence (Applied Biosystems, Inc., Foster City, CA)
used for detection of the PCR product was: BmTC8100-MGB-FAM
(6FAM-AACACCTGGTCTACC-MGBNFQ). The sequences of
the Bm-tph-1 primers for qRT-PCR were #1252 BmWb-tph1.F 59-
GACCGATTTAAACAGTTGCAGTTC-39 and #1251 BmWb-
tph1.R 59-CTACTACAGCTACTTGTCCCTCACCTT-39 and
the Taqman probe sequence was #1250 6FAM-ATCGGT-
GAGCGTATGGCCGAAGG-Tamra.
Primer optimization was done for each primer/probe combi-
nation according to the Applied Biosystems, Inc. standard
protocol. 2.5 ml of RNA extract were used in each 25 ml reaction:
12.5 ml Taqman OneStep RT-PCR Master Mix (Applied
Biosystems), 0.625 ml 406 Multiscribe/RNase inhibitor, and
240 nM probe. The optimal primer concentration determined
for TC8100 was 900 nM of each primer and for tph-1 it was
300 nM forward primer (#1252) and 900 nM reverse primer
(#1251). The plate was run using the Absolute Quantification
module of the Sequence Detection System Program v1.3 on the
Applied Biosystems 7300 Real-Time PCR System; all biological
replicate samples were run in duplicate or triplicate along with
gDNA and negative controls. The cycling conditions were 50uC
for 30 min, 95uC for 10 min, followed by 40 cycles of 95uC for
15 sec and 60uC for 1 min.
Multiplex qRT-PCR and conventional RT-PCR
The same Bm-tph-1 probe sequence (see above) was labeled with
VIC instead of FAM (Applied Biosystems, Inc.) for use in the
multiplex qRT-PCR. Primer and probe optimizations were also
done for the multiplex reaction according to the Applied
Biosystems, Inc. standard protocol. The optimal concentrations
were determined to be 900 nM of both the forward and reverse
TC8100 primers, and 60 nM of the forward tph-1 primer (#1252)
coupled with 600 nM of the reverse tph-1 primer (#1251). Both
probe concentrations were 250 nM and all reactions were done in
a 25 ml total volume with the Taqman One-step RT-PCR Master
mix, and the Multiscribe reverse transcriptase enzyme with RNase
inhibitor (Applied Biosystems, Inc.). 2 ml of template RNA were
added to each reaction and standard qRT-PCR cycling conditions
(listed above) were used.
Assay sensitivity
Sensitivity level was measured both by mixing infective
mosquitoes with unfed mosquitoes and by mixing individual
BmL3 larvae with unfed mosquitoes. For detecting infective
mosquitoes, one mosquito presumed to be infective (14 days after
feeding on infected blood) was added to a pool of uninfected
mosquitoes with total pool sizes of 5–25 mosquitoes. Three
biological replicates were tested to control for the possibility that
the presumed infective mosquito might not contain L3 stage
parasites. In addition, three pools of two presumed infective
mosquitoes with 3 negative mosquitoes were tested as positive
controls. The sensitivity of the L3 detection assay was also
evaluated directly by adding different numbers (10, 20, 25, or 30)
of uninfected mosquitoes to tubes containing a single BmL3
parasite. RNA extraction and multiplex qRT-PCR were per-
formed as described above.
Specificity of the multiplex qRT-PCR assay
Mosquitoes were fed on Brugia pahangi, Wuchereria bancrofti, or
Dirofilaria immitis infected blood and maintained in an insectary
under standard conditions for times required for development of
L3. Mosquitoes were collected on day 11 PBM for B. pahangi, on
day 16 for D. immitis, and on day 15 for W. bancrofti and preserved
in RNAlater. RNA was extracted from 3 biological replicates for
each mosquito/parasite combination from pools comprised of 5
infected and 5 uninfected mosquitoes. All samples were tested in
triplicate using the multiplex qRT-PCR diagnostic assay described
above.
Species confirmation testing
B. malayi and B. pahangi (a closely related cat parasite) are
coendemic in some areas. Since TC8100 transcripts were detected
in both B. malayi and B. pahangi, a different assay was needed to
distinguish between these species. We used conventional RT-PCR
with primers for the rbp-1 gene [Accession # X91064]. Primers
(#1662 Bp-rbp1.F1 59-GAC GTC AGC TTC GTG TT-39 and
#1623-Bp-rbp1.R1 59-AAC ATT TGA AAC GGG AT-39) were
designed to exploit a single nucleotide difference between B.
pahangi and B. malayi. They amplify a 102 base pair product in B.
Molecular Assay for Filarial L3 in Mosquitoes
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pahangi; they do not amplify a sequence in B. malayi. Conventional
RT-PCR using the standard manufacturer’s protocol of the
Qiagen One-step RT-PCR kit was performed with 600 nM of
each primer and 1 ml of template RNA. The cycling and detection
conditions were as described for conventional RT-PCR above
except for the annealing temperature (57uC).
Results
cDNA Library PCR
Table 1 lists the candidate L3-activated gene targets generated
via bioinformatics analysis of the B. malayi Gene Index that met the
criteria listed in the Methods section. These genes were subjected
to additional testing to determine the stage of onset of gene
expression. Table 1 shows expression profiles determined for each
candidate gene based on PCR amplification from BmMf, BmL2,
BmL3, and BmL4 cDNA libraries (no BmL1 cDNA library is
available). Twenty-three of 27 target gene candidates tested by
cDNA library PCR had transcripts expressed in pre-L3 larval
stage cDNA libraries. These candidates were not studied further.
One candidate gene was not amplified in the vector-derived BmL3
stage cDNA library and was dropped from further consideration.
Three candidate genes (TC7917, TC7969, and TC8100) were
selected for further analysis as diagnostic targets based on
successful amplification in the L3 stage cDNA library with no
amplification in the pre-L3 stage cDNA libraries.
RT-PCR of candidate transcripts using RNA from infected
mosquitoes
High quality RNA was extracted from pools of mosquitoes
preserved in RNAlater with 260/280 nm absorbance ratios
between 1.9–2.1 as measured by spectrophotometry. The three
selected gene candidates were tested using RNA isolated from
infected mosquito pools collected daily for 14 days post feeding on
microfilaremic blood. A collagen gene (TC8100) had an
expression signal by conventional RT-PCR first seen in mosqui-
toes 9 days after an infected blood meal (data not shown). This
corresponds to the time when B. malayi L3 usually first appear in
AeL mosquitoes reared under standard laboratory conditions. In
addition, Bm-TC8100 qRT-PCR results confirmed this expression
timeline (Table 2). Therefore, this gene was considered the best
Table 1. cDNA Library PCR Screening of Gene Candidates.
Gene Identifier
Putative Identification based on Protein
similarity matches
BmMf cDNA
Library
BmL2 cDNA
Library
BmL3 cDNA
Library
Mammalian stage cDNA
Libraries: (BmL3d6 or BmL4)
TC7714 Cuticle collagen + + +
TC7770 Glyoxalase II + + +
TC7785 No match + + +
TC7804 Collagen + + + +
TC7822 Calcium-dependent kinase + + +
TC7825 Serpin + +
TC7866 ard-1, putative reductase + + +
TC7871 cpi-2, cystatin + + +
TC7873 alt-1, abundant larval transcript + + +
TC7897 Ubiquinol + + + +
TC7899 Unknown + +
TC7908 Myosin, essential light chain + + + +
TC7917 Pyruvate dehydrogenase +
TC7969 alt-3, abundant larval transcript +
TC7999 Triosephosphate isomerase + + + +
TC8010 cpi-1, cystatin + + +
TC8015 Unknown + + + +
TC8021 Glycosyl transferase + +
TC8023 Unknown + +
TC8026 Unknown + + +
TC8100 Collagen + +
TC8154 Facilitated glucose transporter + + +
TC8221 cpi-1 cystatin +
TC8253 SNS-Rich protein + + + +
TC8257 Unknown + + + +
TC8325 Unknown + + NT
TC8383 Unknown + + + NT
Gene Identifier = TIGR Cluster Number (TC) available at http://compbio.dfci.harvard.edu/tgi/cgi-bin/tgi/gimain.pl?gudb=b_malayi.
+= PCR product detected, blank = no PCR product detected, and NT= not tested.
B. malayi cDNA library abbreviations: BmMf=microfilarial stage, BmL2= L2 stage, BmL3= vector-derived L3 stage, BmL3d6= L3 larvae collected 6 days post mammalian
infection, BmL4=mammalian derived L4 stage.
doi:10.1371/journal.pntd.0000251.t001
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target for an L3 detection assay because it was determined to be
unambiguously L3-activated.
The expression profiles of the other two candidate genes
eliminated them as diagnostic targets. Conventional RT-PCR
results indicated that TC7917 was first expressed on day 7 PBM.
However, qRT-PCR, a more sensitive technique, detected
expression on day 5 PBM, prior to the emergence of L3’s in the
vector. TC7969 (alt-3) expression was consistently detected by
conventional RT-PCR at day 6 PBM corresponding to the earliest
time point that B. malayi L3 have been identified in the bodies of
insectary-reared AeL mosquitoes [22]. However, since no more
than 10% of day 6 PBM mosquitoes are expected to contain
BmL3 stage parasites and since there were 2 or 3 infected
mosquitoes per pool, the detection of alt-3 on day 6 PBM is most
likely due to expression in L2 stage parasites. We then focused on
TC8100.
Expression profile of BmTC8100 and tph-1 as determined
by the qRT-PCR multiplex assay
Table 2 shows the expression profile of BmTC8100 in 5
biological replicates of the infected mosquito time course. Each
mosquito pool contained 2 or 3 infected mosquitoes that had been
collected at daily intervals beginning immediately after ingestion of
infected blood (day 0) and continuing for 14 days. Of the 75
sample pools processed, 73 contained RNA of sufficient quantity
and quality for testing as determined by spectrophotometry. Cycle
threshold (Ct) values for tph-1, the constitutively expressed control
transcript, were in the range of 23.5 to 37.6 with a mean value of
29.4. Ct values for BmTC8100, the L3-activated transcript
candidate, were in the range of 30.2 to 39.1 with a mean value
of 34.1. Ninety-six percent of the mosquito pools contained
parasite RNA as indicated by positive amplification of the tph-1
control gene. Four of the 5 replicate time-course studies detected
TC8100 expression beginning on day 9 or day 10 PBM. This
corresponds to the peak time for appearance of L3. TC8100
expression was detected on day 6 PBM in one of the five mosquito
pool time course sets. TC8100 expression was not detected in
mosquitoes from days 7 or 8 PBM in this set, but it was present in
pools collected on days 9 through 14 PBM. TC8100 expression
was not detected in any mosquito pool collected prior to day 6
PBM. These results indicate that TC8100 expression was only
detected when L3 would be expected to be in mosquitoes; this is
good evidence that the TC8100 collagen gene is L3-activated.
Assay sensitivity
We assessed sensitivity of the TC8100 / tph-1 multiplex qRT-
PCR assay for detecting one B. malayi L3 in pools of 10, 20, 25 or
30 uninfected mosquitoes, with 3 biological replicates for each
sample. RNA extracts ranged in concentration from 130–
1826 ng/ml (Table 3). All samples tested positive for tph-1
indicating that parasite RNA was extracted in all cases with Ct
values ranging from 29.57–31.77. All of the samples with 10 to 25
mosquitoes were also positive for the L3-activated transcript,
TC8100, with Ct values in the range of 36.40–38.67. However,
only one of three biological replicates containing one L3 in a pool
of 30 mosquitoes was positive for the L3 transcript. These results
indicate that the multiplex qRT-PCR BmL3 detection assay
reliably detected a single B. malayi L3 in mosquito pools less than
or equal to 25.
To assess the sensitivity of the assay when L3 are located inside
mosquitoes, we tested pools comprised of one day 14 PBM
mosquito with varying numbers of uninfected mosquitoes (4–24).
Table 2. qRT-PCR Detection of the TC8100 Expression Profile Across a Two-Week Mosquito Time Course.
Mosquito
Timepoint
(#dPBM)
Expected stage
of parasite
development TC8100 Ct value for Each of 5 Biological Replicates Representing the Stage of Expression
(3:5)* (2:8)* (2:8)* (2:8)* (2:8)*
0 Mf - - no RNA - -
1 Mf - - - - -
2 L1 - - - - -
3 L1/L2 - - - - -
4 L1/L2 - no RNA - - -
5 L2 - - neg tph-1
6 L2/L3 - 38.03 - - -
7 L2/L3 - - - - -
8 L2/L3 - - - - -
9 L3 35.33 33.68 31.17 neg tph-1 34.6
10 L3 34.36 33.27 30.32 34.09 35.65
11 L3 34.18 33.25 30.86 33.55 neg tph-1
12 L3 32.62 32.97 31.09 34.74 35.06
13 L3 35.01 34.83 31.84 36.36 35.32
14 L3 33.70 34.29 33.43 37.81 35.56
# dPBM=number of days post blood meal (after mosquitoes were fed on infected blood).
*ratio of infected mosquitoes to total pool size.
No RNA indicates a faulty RNA Extraction as detected by spectrophotometry.
Neg tph-1 indicates no parasite RNA was extracted in that mosquito pool.
‘‘-’’ indicates no TC8100 RNA was detected in that sample.
Ct value = cycle threshold value (product amplification detected to cross the threshold).
doi:10.1371/journal.pntd.0000251.t002
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Since not all day 14 PBM mosquitoes would be expected to
contain L3, it was not surprising that 7 of these pools tested
negative for both tph-1 and TC8100 RNA (Table 4). The other 14
pools all tested positive for both tph-1 and TC8100 transcripts
indicating that they contained L3. Of the 3 biological replicates for
each pool size, at least one tested positive for TC8100, indicating
that the assay can detect a single infective mosquito in a pool of 25
mosquitoes. Thus, both assessments of sensitivity suggested a
maximum pool size of 25 mosquitoes.
Assay specificity
D. immitis infected mosquitoes tested negative by real-time qRT-
PCR for both the tph-1 and the TC8100 transcripts using the
primers and probes reported in this paper (Table 5). W. bancrofti
infected mosquitoes tested positive for the tph-1 control transcript
but not TC8100, the L3-detection transcript. Both of these
transcripts were detected in B. pahangi infected mosquitoes. These
results indicate that the TC8100 Brugia L3 detection assay is genus-
specific but not species-specific.
Species confirmation testing
A 102 base pair rbp-1 RT-PCR product was detected in all B.
pahangi samples, while all B. malayi samples were negative for the
rbp-1 transcript (data not shown) using the primers reported in this
paper. This shows that the rbp-1 assay can be used to detect the
samples containing B. pahangi.
Discussion
Several technical advances were required for a molecular L3
detection assay including a simple method for preserving parasite
RNA in mosquitoes, a method for efficiently extracting RNA from
parasites in pools of mosquitoes, identification of an L3-activated
gene, and a method to sensitively detect that gene’s transcript. We
found that parasite RNA could be efficiently extracted from
infected mosquitoes preserved in RNAlater (Ambion, Inc.) using a
simple BB-grinding technique and a phenol-based extraction
procedure. We then identified TC8100 as a L3-activated
transcript and developed methods for its detection by conventional
RT-PCR and qRT-PCR.
The B. malayi EST genome project provided an important
starting point in our search for an L3-activated transcript with
information on genes expressed in several parasite stages essential
for our initial search. A L3 assay required an authentic L3-
activated transcript with no expression in the early larval stages
present in mosquitoes (Mf, L1 or L2). We carefully evaluated a
panel of candidate genes; only the collagen gene TC8100 was
confirmed to be a truly L3-activated transcript.
Time course studies were performed with RNA isolated from
infected mosquitoes rather than with parasites isolated at different
times after mosquito feeding. This approach proved the practical
point that the target parasite sequence could be detected in
infected mosquitoes preserved in RNAlater. The development of
B. malayi in mosquitoes is not completely synchronous. Testing
multiple replicates of infected mosquitoes at daily intervals and
using 2–3 infected mosquitoes in each pool permitted us to be
certain that we were covering the entire developmental timeline of
the parasites in mosquitoes. Previous studies have documented the
developmental time course of B. malayi in AeL mosquitoes reared
under the laboratory conditions used in this study [22]. Within
48 hours of a blood meal, the majority of ingested microfilariae
exsheathe and reach the ‘sausage’ stage (L1). The first molt to the
L2 stage takes place between days 3–6, and the second molt to the
L3 stage begins as early as day 6 but peaks between days 9–11
PBM. Therefore, a transcript that is truly L3-activated would be
expected to have no expression prior to day 6 PBM, with most
samples beginning expression by day 9, 10 or 11 PBM.
The expression profile of TC8100 was consistent with the BmL3
developmental timeline; the majority of the samples tested showed
expression beginning at day 9 PBM corresponding to the peak
timing of the L3 molt. Only one sample showed expression of
TC8100 at day 6 PBM, which is the earliest reported time of L3
development. In addition to being activated at the beginning of L3
development, it is important to note that a successful diagnostic
target must also continue to be expressed throughout the lifespan
of the L3 parasite so that a mosquito containing L3 of any age can
Table 3. Detection of one B. malayi L3 added to pools of uninfected mosquitoes.
# BmL3 worms in the pool # mosquitoes in the pool RNA concentration (ng/ml) tph-1 qRT-PCR Ct value* TC8100 qRT-PCR Ct value*
2 d14 PBM 30 130 30.0 38.2
2 d14 PBM 30 756 29.0 37.9
1 10 279 30.4 37.1
1 10 707 29.6 37.3
1 10 571 30.3 37.7
1 20 798 30.2 37.6
1 20 1198 31.0 37.2
1 20 1187 31.2 37.3
1 25 1400 30.8 36.4
1 25 1387 30.0 37.6
1 25 1360 30.9 38.7
1 30 1180 31.3 38.5
1 30 871 31.8 -
1 30 1826 30.6 -
*All samples were run in triplicate and average Ct values are shown.
Dashed lines indicate that the TC8100 RNA was not detected in the sample.
doi:10.1371/journal.pntd.0000251.t003
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be detected. Our data showed that TC8100 transcripts were
present in early L3 and in later L3.
The constitutively expressed B. malayi gene tph-1 complemented
TC8100 because it provided a useful marker to indicate the
presence (and successful extraction) of filarial RNA in mosquito
samples. The tph-1 primers also amplified a homologous target
sequence in RNA from the closely related filarial species W.
bancrofti but not in RNA from the more distantly related animal
Table 4. Detection of a single infective mosquito in mosquito pools.
# infective mosquitoes
in the pool Total Pool Size
RNA concentration
(ng/ml)
tph-1 qRT-PCR
Ct value*
TC8100 qRT-PCR
Ct value*
1 5 143 28.9 34.5
1 5 158 - -
1 5 185 27.6 34.1
1 8 303 - -
1 8 480 28.8 35.1
1 8 363 - -
1 10 348 29.0 35.1
1 10 399 27.4 33.8
1 10 354 29.3 35.7
1 12 318 27.8 34.3
1 12 335 29.3 35.8
1 12 198 - -
1 15 402 - -
1 15 562 29.0 35.8
1 15 323 30.0 35.5
1 20 642 27.1 34.6
1 20 833 28.7 35.9
1 20 552 - -
1 25 894 - -
1 25 799 28.9 35.7
1 25 905 28.0 33.8
*All samples were run in triplicate and average Ct values are shown.
Dashed lines indicate samples where no B. malayi RNA was detected.
doi:10.1371/journal.pntd.0000251.t004
Table 5. Specificity Testing of the Brugia L3 Detection Assay.
RNA Sample No.
# infective mosquitoes
(time PBM) Total Pool Size
RNA concentration
(ng/ul) tph-1 Ct value* TC8100 Ct value*
BmL3-03 5(d14) 30 1373 28.2 34.9
DiL3-01 5 (d16) 10 694 - -
DiL3-02 5 (d16) 10 448 - -
DiL3-03 5 (d16) 10 573 - -
WbL3-01 5 (d15) 10 712 24.5 -
WbL3-02 5 (d15) 10 739 25.5 -
WbL3-03 5 (d15) 10 997 25.6 -
BpL3-01 5 (d11) 10 583 24.5 30.5
BpL3-02 5 (d11) 10 827 25.1 31.0
BpL3-03 5 (d11) 10 737 26.8 34.6
*All samples were run in triplicate and average Ct values are shown.
BmL3= B. malayi L3, DiL3=D. immitis L3, WbL3=W. bancrofti L3, BpL3= B. pahangi L3 tph-1 is a constitutive target that is transcribed in all stages of Brugia and
Wuchereria.
TC8100 is an L3-activated transcript that is only present in Brugia L3.
PBM=days post blood meal.
Dashed lines indicate that the RNA target was not detected in the sample.
doi:10.1371/journal.pntd.0000251.t005
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filarid D. immitis. Therefore, in settings where there is no overlap
between Brugia and Wuchereria infections, the TC8100/tph-1
multiplex assay could be used to evaluate infection and infectivity
rates simultaneously.
One consideration for the implementation of any new
diagnostic technique is the practicality of using it as a surveillance
tool. The storage of vectors in RNAlater eliminates any major
limitations regarding mosquito collection. The mosquitoes can be
stored for one day at ambient temperature and for at least several
months at 220uC. Any laboratory that is already set-up to
perform PCR would be able to use the conventional RT-PCR
assay with no additional equipment investment. For the real-time
assay, the investment of a real-time PCR machine would be
necessary, but the cost of such instrumentation is dropping to
levels as low as $16,000, making it a reasonable investment option.
At this time, the cost of the RNA extraction and RT-PCR is
approximately $5 per pool of mosquitoes, or $0.22 per mosquito.
If the reactions are run in duplicate, the cost per pool would be
approximately $6.30, or $0.25 per mosquito. This compares to the
current cost of $5.00 per pool for the xenomonitoring DNA assay.
The throughput for the conventional assay for a single technician
would be estimated at 2,000 mosquitoes per week (80 pools with
25 mosquitoes per pool), while the real-time assay throughput is
estimated at 4,000 mosquitoes per week (160 pools of 25
mosquitoes). The advantage to the real-time assay includes both
a higher throughput level (reduced labor cost), as well as a
reduction in potential contamination due to the elimination of
post-PCR product handling. The real-time assay is a more cost
efficient method, and thus, would be the recommended transmis-
sion surveillance tool wherever possible anticipating that the cost
will decrease as time goes on.
A potential limitation of this L3 detection assay is that it cannot
differentiate between B. malayi and B. pahangi (a zoonotic parasite)
in mosquitoes. However, the same limitation applies to the
traditional means of detecting L3 in mosquitoes, namely dissection
with microscopy [23]. Our results showed that the rbp-1 assay is
specific for B. pahangi. This test can be used to help clarify results
obtained from mosquitoes collected in areas where the two Brugia
species are co-endemic. Only positive samples would need to be
tested in this way, and the number of positive mosquito pools
should become very small as infection rates fall in humans and
mosquitoes following MDA.
One key limitation of this study is that our assays have not yet
been tested with field-caught mosquitoes. Nevertheless, there have
been many calls for the development of molecular tests for
detection of filarial L3 in vectors [16,24]. Our results serve as a
proof of principle that L3-specific assays are feasible. Field studies
are now needed to assess the practical value of such tests as tools
for documenting the interruption of transmission in the context of
filariasis elimination programs.
Finally, we need to note that the L3-detection assay based on
TC8100 is specific to Brugia and does not detect L3 of W. bancrofti,
the parasite responsible for the majority of the global burden of
LF. Clearly, there is a need for the development of a diagnostic
tool for the detection of WbL3 infective vectors as well.
Surprisingly, we have been unable to identify the orthologue of
this Brugia L3 activated gene, BmTC8100, in W. bancrofti. We are
actively testing potential targets that can be used to detect W.
bancrofti L3 in mosquitoes.
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